Vycor Medical
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-4.53-4.50-2.27-6.34-1.28-3.83-2.89-5.54-7.03-36.11-6.25-3.83
Price/Sales ratio
14.708.232.586.761.172.232.282.082.331.722.421.17
Price/Book Value ratio
6.368.18-142.27115.03-2.30-2.44-1.31-1.21-0.97-0.75-1.05-2.30
Price/Cash Flow ratio
-6.80-8.02-7.56-17.76-6.80458.77-10.48135.87-13.1485.52-19.55458.77
Price/Free Cash Flow ratio
-6.40-6.41-6.78-13.18-5.46-64.91-8.38-170.73-12.98125.57-19.19-19.19
Price/Earnings Growth ratio
N/A0.080.100.130.060.080.650.110.256.60-0.370.08
Dividend Yield
N/A1.78%4.77%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
87.49%85.58%87.28%83.60%88.76%90.10%88.40%90.32%88.5%90.07%88.96%88.76%
Operating Profit Margin
-218.52%-174.85%-109.54%-94.77%-87.30%-48.93%-63.16%-31.29%-25.06%2.75%-30.96%-87.30%
Pretax Profit Margin
-323.90%-182.90%-113.73%-106.64%-91.38%-53.73%-70.07%-29.30%-32.68%-4.31%-38.34%-91.38%
Net Profit Margin
-323.90%-182.90%-113.73%-106.64%-91.38%-58.36%-78.83%-37.57%-33.18%-4.77%-38.79%-91.38%
Effective Tax Rate
-3.22%-2.29%-3.69%-3.60%0.10%-8.62%-12.49%-28.22%-1.54%N/AN/AN/A
Return on Assets
-106.18%-102.96%-111.24%-101.90%-132.15%-79.20%-91.25%-55.96%-47.18%-7.02%-50.05%-132.15%
Return On Equity
-140.18%-181.77%6249.64%-1813.61%179.41%63.85%45.43%21.85%13.80%2.09%18.28%63.85%
Return on Capital Employed
-94.57%-173.77%6019.28%-1611.65%171.39%53.53%41.12%19.68%10.96%-1.30%14.20%53.53%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.16N/A
Quick Ratio
2.410.640.220.280.230.180.100.080.070.080.050.18
Cash ratio
2.040.390.030.150.040.020.010.020.010.010.000.02
Days of Sales Outstanding
36.1434.0837.3829.1062.2667.6350.8933.0446.6153.7853.7767.63
Days of Inventory outstanding
784.69650.60403.31343.70437.14523.96499.00562.20645.87589.60721.90437.14
Operating Cycle
820.83684.69440.69372.80499.41591.59549.90595.24692.49643.38735.16499.41
Days of Payables Outstanding
517.73556.81493.98227.09200.05610.78493.53616.93519.15296.63590.94200.05
Cash Conversion Cycle
303.10127.87-53.28145.70299.35-19.1856.36-21.68173.34346.75-359.16-19.18
Debt Ratios
Debt Ratio
0.080.150.380.210.490.530.900.891.150.973.960.49
Debt Equity Ratio
0.110.27-21.363.90-0.67-0.43-0.44-0.34-0.33-0.29-1.33-0.43
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A-0.08-0.06-0.05-0.04-0.05N/A
Total Debt to Capitalization
0.100.211.040.79-2.07-0.76-0.81-0.53-0.51-0.40-0.51-2.07
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-4.26N/A
Cash Flow to Debt Ratio
-8.39-3.69-0.87-1.65-0.500.01-0.270.02-0.210.03-0.15-0.50
Company Equity Multiplier
1.321.76-56.1717.79-1.35-0.80-0.49-0.39-0.29-0.29-0.33-1.35
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-2.16-1.02-0.34-0.38-0.170.00-0.210.01-0.170.02-0.12-0.17
Free Cash Flow / Operating Cash Flow Ratio
1.061.251.111.341.24-7.061.24-0.791.010.681.011.01
Cash Flow Coverage Ratio
-8.39-3.69-0.87-1.65-0.500.01-0.270.02-0.210.03-0.15-0.50
Short Term Coverage Ratio
-8.39-3.69-0.87-1.65-0.500.01-0.330.03-0.250.03-0.18-0.50
Dividend Payout Ratio
N/A-8.05%-10.87%N/AN/AN/AN/AN/AN/AN/AN/AN/A